chemotherapy

You have access
¹⁸F-AraG PET for CD8 Profiling of Tumors and Assessment of Immunomodulation by Chemotherapy
Jelena Levi, Samuel Goth, Lyna Huynh, Tina Lam, Tony L. Huynh, Brailee Schulte and Juliet A. Packiasamy

Journal of Nuclear Medicine June 1, 2021, 62 (6) 802-807; DOI: https://doi.org/10.2967/jnumed.120.249078
You have access
Diagnosis, Treatment Response, and Prognosis: The Role of ¹⁸F-DOPA PET/CT in Children Affected by Neuroblastoma in Comparison with ¹²³I-mIBG Scan: The First Prospective Study
Arnoldo Piccardo, Giovanni Morana, Matteo Puntoni, Sara Campora, Stefania Sorrentino, Pietro Zucchetta, Martina Ugolini, Massimo Conte, Angelina Cistaro, Giulia Ferrarazzo, Marco Pescetto, Marco Lattuada, Gianluca Bottoni, Alberto Garaventa, Luca Giovanella and Egesta Lopci

Journal of Nuclear Medicine March 1, 2020, 61 (3) 367-374; DOI: https://doi.org/10.2967/jnumed.119.232553
You have access
Long-Term Clinical and Neuronuclear Imaging Sequelae of Cancer Therapy, Trauma, and Brain Injury
April Alcantara, Gholam R. Berenji, Carole S. Scherling, Beata Durcanova, Daniel Diaz-Aguilar and Daniel H.S. Silverman

Journal of Nuclear Medicine December 1, 2019, 60 (12) 1682-1690; DOI: https://doi.org/10.2967/jnumed.119.237578
You have access
Clinical Outcomes of ¹⁷⁷Lu-PSMA Radioligand Therapy in Earlier and Later Phases of Metastatic Castration-Resistant Prostate Cancer Grouped by Previous Taxane Chemotherapy
Thomas W. Barber, Aviral Singh, Harshad R. Kulkarni, Karin Niepsch, Baki Billah and Richard P. Baum

Journal of Nuclear Medicine July 1, 2019, 60 (7) 955-962; DOI: https://doi.org/10.2967/jnumed.118.216820
You have access
Prospective Evaluation of Changes in Tumor Size and Tumor Metabolism in Patients with Advanced Gastric Cancer Undergoing Chemotherapy: Association and Clinical Implication
Seongyeol Park, Seunggyun Ha, Hyun Woo Kwon, Woo Hyoung Kim, Tae-Yong Kim, Do-Youn Oh, Gi Jeong Cheon and Yung-Jue Bang

Journal of Nuclear Medicine June 1, 2017, 58 (6) 899-904; DOI: https://doi.org/10.2967/jnumed.116.182675
You have access
Early Prediction of Tumor Response to Treatment: Preclinical Validation of ^99mTc-Duramycin
Filipe Elvas, Christel Vangestel, Koon Pak, Peter Vermeulen, Brian Gray, Sigrid Stroobants, Steven Staelens and Leonie Wyffels

Journal of Nuclear Medicine May 1, 2016, 57 (5) 805-811; DOI: https://doi.org/10.2967/jnumed.115.168344
You have access
Postchemotherapy and Tumor-Selective Targeting with the La-Specific DAB4 Monoclonal Antibody Relates to Apoptotic Cell Clearance
Fares Al-Ejeh, Alexander H. Staudacher, Douglas R. Smyth, Jocelyn M. Darby, Delphine Denoyer, Chris Tsopelas, Rodney J. Hicks and Michael P. Brown

Journal of Nuclear Medicine May 1, 2014, 55 (5) 772-779; DOI: https://doi.org/10.2967/jnumed.113.130559
You have access
Targeted Chemoradiation in Metastatic Colorectal Cancer: A Phase I Trial of ¹³¹I-huA33 with Concurrent Capecitabine
Rebecca A. Herbertson, Niall C. Tebbutt, Fook-Thean Lee, Sanjeev Gill, Bridget Chappell, Tina Cavicchiolo, Tim Saunder, Graeme J. O’Keefe, Aurora Poon, Sze Ting Lee, Roger Murphy, Wendie Hopkins, Fiona E. Scott and Andrew M. Scott

Journal of Nuclear Medicine April 1, 2014, 55 (4) 534-539; DOI: https://doi.org/10.2967/jnumed.113.132761
You have access
Combination of ¹⁸F-FDG PET/CT and Diffusion-Weighted MR Imaging as a Predictor of Histologic Response to Neoadjuvant Chemotherapy: Preliminary Results in Osteosarcoma
Byung Hyun Byun, Chang-Bae Kong, Ilhan Lim, Chang Woon Choi, Won Seok Song, Wan Hyeong Cho, Dae-Geun Jeon, Jae-Soo Koh, Soo-Yong Lee and Sang Moo Lim

Journal of Nuclear Medicine July 1, 2013, 54 (7) 1053-1059; DOI: https://doi.org/10.2967/jnumed.112.115964
You have access
Apoptosis Imaging Probe Predicts Early Chemotherapy Response in Preclinical Models: A Comparative Study with ¹⁸F-FDG PET
Shaoli Song, Chiyi Xiong, Wei Lu, Geng Ku, Gang Huang and Chun Li

Journal of Nuclear Medicine January 1, 2013, 54 (1) 104-110; DOI: https://doi.org/10.2967/jnumed.112.109397

Main menu

User menu

Search

chemotherapy